Please login to the form below

Not currently logged in
Email:
Password:

canakinumab

This page shows the latest canakinumab news and features for those working in and with pharma, biotech and healthcare.

Alcon's return to growth gives Novartis 'options', says CEO

Alcon's return to growth gives Novartis 'options', says CEO

A string of positive pipeline news - including a positive FDA advisory committee meeting for CAR-T cancer immunotherapy CTL019 and encouraging data on ophthalmic drug brolucizumab and ACZ885 (canakinumab) in heart

Latest news

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics